Li S, Zheng H, Ge Q, Xia S, Zhang K, Wang C, Wang F.  Effectiveness and Safety of Apatinib Plus Programmed Cell Death Protein 1 Blockades for Patients with Treatment-refractory Metastatic Colorectal Cancer: A Retrospective Exploratory Study.  J Cancer Prev 2023;28:106-114.  https://doi.org/10.15430/JCP.2023.28.3.106